Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, Amanda Eaton, Marcella Sarzotti‐Kelsoe et al.|Science|2022Cited by 1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trialSpyros Chalkias, Rituparna Das, Frank Eder et al.|Nature Medicine|2022Cited by 144
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy TrialPeter B. Gilbert, Richard A. Koup, David C. Montefiori et al.|medRxiv|2021Cited by 138
Phase 3 Trial of mRNA-1273 during the Delta-Variant SurgeLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|New England Journal of Medicine|2021Cited by 63